May 24, 2018
New Review Exploring the Role of the Haematologist in Finding and Treating Gaucher Disease Type 1
Apr 27, 2018
Sanofi: First-quarter 2018 Business EPS up 1.4% at CER
Apr 25, 2018
Applied BioMath, LLC Announces Collaboration with Sanofi Genzyme for Systems Pharmacology Modeling of Bispecific Antibody Therapeutics in Immunology
Mar 27, 2018
Accreditation Council Appoints Global Medical Affairs Expert Dr. Robin Winter-Sperry to Board of Governors
Mar 05, 2018
Can Do MS Launches New Educational Initiative MS Path 2 Care for People Impacted by Multiple Sclerosis
Feb 13, 2018
Dr. Richard Douglas Joins MaxCyte Board
Feb 07, 2018
Sanofi Delivers 2017 Business EPS in line with Guidance
Feb 06, 2018
Kymera Therapeutics Appoints Industry Veteran Mark E. Nuttall, Ph.D., as Chief Business Officer
Feb 06, 2018
British Columbia includes (Pr)LEMTRADA® (alemtuzumab) on provincial drug program for eligible patients
Dec 13, 2017
Audentes Therapeutics Appoints Mark A. Goldberg, M.D. to its Board of Directors
Nov 09, 2017
Mylan Launches Generic Clolar® for Injection
Nov 01, 2017
Sigilon Therapeutics Appoints Eric Shaff to Board of Directors
Oct 03, 2017
Dr. Gloria Matthews Joins MiMedx As Its Senior Vice President Of Research And Development
Sep 21, 2017
Nektar Therapeutics Appoints Biotechnology Executive Jeff Ajer as New Board Member
Sep 05, 2017
Enzyvant Receives FDA Rare Pediatric Disease Designation for Investigational Therapy RVT-802
Sep 01, 2017
Sanofi Receives Tentative FDA Approval of Admelog® (insulin lispro injection) 100 Units/mL
Aug 01, 2017
Prince Edward Island includes LEMTRADA® (alemtuzumab) on provincial drug program for eligible patients
Jul 31, 2017
Sanofi Raises FY 2017 Business EPS Guidance to Broadly Stable at CER